Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort (BMC Psychiatry, (2022), 22, 1, (342), 10.1186/s12888-022-03983-3)

Abstract

Following the publication of the original article [1], the authors identified errors in the figure captions. Fig. 1 aDefined using the International Diabetes Federation definition; bBMI by 10 kg.m-2. c Estimated risk of death from cardiovascular diseases within 10 years using the Systematic Coronary Risk Estimation. Models were adjusted for age, sex, smoking status, and psychotropic medication (classified by the risk of weight gain), except the model for CVD which was adjusted only for psychotropic medication. 1 Models fitted with random effect at observation level. 2 Models fitted with random effect at patient level. ***: p-value < 0.001; **: p-value ≤ 0.01; *: p-value ≤ 0.05. Correction for multiple testing was applied using false discovery rate. Abbreviations: BMI body mass index, CVD cardiovascular diseases, HDL high-density lipoprotein, MetS metabolic syndrome, N number. The original article [1] has been corrected.